Vaccines Against Bacterial and Viral Infections (2023)
Vaccines Against Bacterial and Viral Infections (Course #: 0158.1270) |
|
|
Instructors: |
Daniel Cohen (Tel Aviv University, Israel) Khitam Muhsen (Tel Aviv University, Israel) Elizabeth Miller (London School of Hygiene & Tropical Medicine, UK; Tel Aviv University, Israel) Jonathan Zenilman (Johns Hopkins University, USA) Myron Levine (University of Maryland, Baltimore, USA) Ronald Ellis (Editor-in-Chief, Human Vaccines & Immunotherapeutics) Michal Mandelboim (Tel Aviv University, Israel) Orna Mor (Tel Aviv University, Israel) |
|
Date and Time: |
July 9-13, 2023 M, W, Th 14:00-18:30 | S, T 14:00-19:00 |
|
Location: |
Room TBA, Sackler Faculty of Medicine |
|
Final Exam: |
July 14, 2023 | 9:00-11:00 | Room TBA |
|
Pre-requisites: |
None |
|
Credits: |
2 |
|
Registration Status: |
OPEN |
| Application: |
Apply now: English (International) | Hebrew (Israeli) |
|
Course Syllabus The course syllabus can be found here. |
|
|
Course Description This course will cover key concepts in vaccinology in general, integrating references to vaccine development, evaluation and current immunization strategies against COVID-19 and other emerging diseases such as Ebola-Sudan and monkeypox. The course will review the evolution of vaccine development approaches and present the characteristics of currently licensed vaccines and those authorized for emergency use. The process from conception to R&D, and to first-in-man studies and further evaluation of safety, immunogenicity and efficacy of candidate vaccines through clinical development phases will be presented and analyzed. Methods to quantify the induced immune response and the protective efficacy conferred by vaccine candidates will be reviewed, and the notion of correlates of protection will be elaborated upon. Post-licensure approaches in the evaluation of vaccines for effectiveness, impact and signal of detection of adverse events will be presented and discussed. Highlights and challenges of the present immunization programs worldwide will be described vis-à-vis the burden of corresponding vaccine-preventable diseases. Special attention will be given to the analysis of psychosocial factors associated with hesitancy to vaccination in various populations. Lecturers will present accomplishments and challenges with selected licensed and investigational vaccines. Throughout, the course will emphasize the importance of the use of advanced epidemiological tools to prioritize the development of new vaccines and assess existing immunization programs. |
|
|
Requirements Participants must pass the final exam with a grade of at least 60 (D) to receive academic credit for the course. Non-credit participants are not required to take the final exam. |
|
| Lecturer Bio | |
 |
Professor, School of Public Health, Tel Aviv University, Israel |
 |
Associate Professor, School of Public Health, Tel Aviv University, Israel |
 |
Professor, London School of Hygiene and Tropical Medicine, United Kingdom; School of Public Health, Tel Aviv University, Israel |
 |
Professor, Bloomberg School of Public Health, Johns Hopkins University |
 |
Prof. Myron M. Levine, MD, DTPH Professor, School of Medicine, University of Maryland, Baltimore, USA |
 |
Editor-in-Chief, "Human Vaccines and Immunotheraputics" |
 |
Associate Professor, School of Public Health, Tel Aviv University, Israel |
 |
Associate Professor, School of Public Health, Tel Aviv University, Israel |
Contact Information
International: Ms. Saritte Perlman | summersph@tauex.tau.ac.il | +972-(0)3-640-7796
Israeli: Hebrew Website
